Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2004

View Archived Issues

Targeting macrophage NF-kappaB activity may improve arthritis in vivo

Risedronate found effective in osteoporotic women treated with gastric acid inhibitors

Lipid profile changes found with exemestane in breast cancer patients

Novel 5-HT6 receptor ligands designed by GSK scientists

Two series of MCH receptor antagonists developed at Neurocrine

Millennium presents new ALK5 inhibitors and their potential applications

Ono researchers develop novel chemokine CCR5 antagonists

New ZAP70 and Syk kinase inhibitors claimed by NeoGenesis

New beta-secretase inhibitors under evaluation at GSK

KuDOS and Maybridge collaborate to develop new PARP inhibitors

NeuroSearch scientists prepare and test new KCNQ channel modulators

Serotonin receptor agonists for treatment of ocular hypertension and glaucoma

Development of novel topoisomerase inhibitors for solid tumor therapy

Angelini to launch prulifloxacin in Italy

Pyrazine nucleosides target hepatitis C virus polymerase

Fast track status for doripenem for nosocomial pneumonia

Promising antifungal compound effective in vitro and in vivo

Kahalalide F enters phase II trials for severe psoriasis

Novel low molecular weight anti-HIV agents by Merck & Co.

Start-up of Merck Pharma GmbH

Nuvelo to gain worldwide rights to alfimeprase

Approvable letter for Nascobal Nasal Spray

Pivotal study compares Numax to Synagis for RSV

Maxim to close Ceplene treatment protocol and withdraw NDA

Axcan launches URSO Forte

Reata Discovery licenses novel anticancer compounds

MD-1100 enters phase I study for IBS

Treatment phase begins in pivotal TRIUMPH study of eculizumab for PNH

Sosei launches U.S. company targeting CNS disorders

Sucampo and Takeda enter collaboration and license agreement for lubiprostone

Antiinflammatory mechanism of ajulemic acid examined in vitro

Everolimus improves methotrexate efficacy in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...